Evolent Health, Inc. (EVH) stock
EVHNYSEServices-Management ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3065% below fair value
$3.93−0.69 (-14.94%)
Close on Nov 18, 2026Market cap $444.32MP/E –Yield –
Evolent Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Evolent Health's operating income for the twelve months ending Jun 30, 2026 was -$427.51M. For fiscal 2025 it was -$410.14M. The highest annual figure on record is $3.64M in fiscal 2022.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$410.14M | – |
| FY2024 | Dec 31, 2024 | -$40.49M | – |
| FY2023 | Dec 31, 2023 | -$71.21M | -2055.3% |
| FY2022 | Dec 31, 2022 | $3.64M | – |
| FY2021 | Dec 31, 2021 | -$42.41M | – |
| FY2020 | Dec 31, 2020 | -$262.85M | – |
| FY2019 | Dec 31, 2019 | -$308.89M | – |
| FY2018 | Dec 31, 2018 | -$47.48M | – |
| FY2017 | Dec 31, 2017 | -$72.84M | – |
| FY2016 | Dec 31, 2016 | -$237.42M | – |
| FY2015 | Dec 31, 2015 | -$42.97M | – |
| FY2014 | Dec 31, 2014 | $0 | – |
| FY2013 | Dec 31, 2013 | -$21.16M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.56M | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.60M | – |
| Q4 FY2025 | Dec 31, 2025 | -$408.23M | – |
| Q3 FY2025 | Sep 30, 2025 | $886.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.17M | -115.0% |
| Q1 FY2025 | Mar 31, 2025 | -$1.62M | – |
| Q4 FY2024 | Dec 31, 2024 | -$18.60M | – |
| Q3 FY2024 | Sep 30, 2024 | -$16.27M | – |
| Q2 FY2024 | Jun 30, 2024 | $7.79M | – |
| Q1 FY2024 | Mar 31, 2024 | -$13.41M | – |
| Q4 FY2023 | Dec 31, 2023 | -$21.35M | – |
| Q3 FY2023 | Sep 30, 2023 | -$17.94M | -238.5% |
| Q2 FY2023 | Jun 30, 2023 | -$21.57M | – |
| Q1 FY2023 | Mar 31, 2023 | -$10.36M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.88M | – |
| Q3 FY2022 | Sep 30, 2022 | $12.95M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.63M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.80M | – |
| Q4 FY2021 | Dec 31, 2021 | -$12.21M | -370.2% |
| Q3 FY2021 | Sep 30, 2021 | -$6.58M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.67M | – |
| Q1 FY2021 | Mar 31, 2021 | -$15.95M | – |
| Q4 FY2020 | Dec 31, 2020 | $4.52M | – |
| Q3 FY2020 | Sep 30, 2020 | -$16.45M | – |
| Q2 FY2020 | Jun 30, 2020 | -$225.83M | – |
| Q1 FY2020 | Mar 31, 2020 | -$25.09M | – |
| Q4 FY2019 | Dec 31, 2019 | -$216.87M | – |
| Q3 FY2019 | Sep 30, 2019 | -$20.14M | – |
| Q2 FY2019 | Jun 30, 2019 | -$25.23M | – |
| Q1 FY2019 | Mar 31, 2019 | -$46.65M | – |
| Q4 FY2018 | Dec 31, 2018 | -$13.35M | – |
| Q3 FY2018 | Sep 30, 2018 | -$11.03M | – |
| Q2 FY2018 | Jun 30, 2018 | -$8.97M | – |
| Q1 FY2018 | Mar 31, 2018 | -$14.13M | – |
| Q4 FY2017 | Dec 31, 2017 | -$18.25M | – |
| Q3 FY2017 | Sep 30, 2017 | -$14.02M | – |
| Q2 FY2017 | Jun 30, 2017 | -$19.12M | – |
| Q1 FY2017 | Mar 31, 2017 | -$21.46M | – |
| Q4 FY2016 | Dec 31, 2016 | -$33.87M | – |
| Q3 FY2016 | Sep 30, 2016 | -$15.84M | – |
See a number that looks wrong?